4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-22-013870
Options or other derivatives
- Chief Medical Officer acquired 46,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| McClure Matthew W. Chief Medical Officer | 2022-07-07 | Grant or award · Stock Option (Right to Buy) | +46,000 | 46,000 | D | ||
Loading xslF345X03/doc1.xml…